LOTUS PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108 TWD | +0.47% |
|
-4.42% | -.--% |
Chart calendar Lotus Pharmaceutical Co., Ltd.
0e797feb9727c1526c4736ff.VwiTAIycd8PIrD0bsO3IJaWYnuiM0Af0kGH_ooEk1E0.AzjCQ9nKAJT46RBUiLr7dPrTxI-741XCxQXK6LBhgDghYMJxufQVpJneZA~55effc57a41b4e9ef99e388d06007716
Upcoming events on Lotus Pharmaceutical Co., Ltd.
Past events on Lotus Pharmaceutical Co., Ltd.
| 2024-04-09 02:00 am | Biotechnology and Medical Care Industry Investor Conference |
| 2024-03-28 03:30 am | Mega Securities Investor Conference |
| 2024-03-19 03:30 am | UBS Securities Investor Conference |
| 2024-03-19 02:00 am | Q4 2023 Earnings Call |
| 2024-03-14 10:30 am | Q4 2023 Earnings Release |
| 2024-03-08 04:01 am | February 2024 Sales and Revenue Release |
| 2024-02-07 02:32 am | January 2024 Sales and Revenue Release |
| 2024-01-10 06:00 am | December 2023 Sales and Revenue Release |
| 2023-11-14 04:00 am | Q3 2023 Earnings Call |
| 2023-11-09 | October 2023 Sales and Revenue Release |
| 2023-11-08 | Q3 2023 Earnings Release |
| 2023-10-15 09:00 pm | JP Morgan Global Healthcare Shanghai Conference |
| 2023-10-11 04:55 am | September 2023 Sales and Revenue Release |
| 2023-09-11 11:18 pm | August 2023 Sales and Revenue Release |
| 2023-08-15 04:00 am | KGI Securities Investor Conference |
| 2023-08-15 02:00 am | Q2 2023 Earnings Call |
| 2023-08-11 04:06 am | Q2 2023 Earnings Release |
| 2023-08-10 05:00 am | July 2023 Sales and Revenue Release |
| 2023-07-19 02:00 am | Yuanta Securities Investor Conference |
| 2023-07-18 02:00 am | MasterLink Securities Investor Conference |
Past dividends on Lotus Pharmaceutical Co., Ltd.
| 2023-07-04 | 3.459921 TWD |
| 2022-08-03 | 1.931215 TWD |
| 2021-07-06 | Annual 0.35 TWD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 9 175 9 014 1.78% | 10 729 10 686 0.4% | 12 649 12 773 -0.97% | 14 633 14 393 1.67% | 16 958 17 025 -0.39% | 18 818 |
|
EBITDA Million TWD | Released Forecast Spread | 1 700 1 965 -13.49% | 2 322 2 384 -2.59% | 3 054 3 016 1.26% | 5 048 4 930 2.4% | 6 114 6 401 -4.48% | 6 970 |
|
EBIT Million TWD | Released Forecast Spread | 1 113 1 451 -23.3% | 1 613 1 621 -0.51% | 2 295 2 383 -3.67% | 4 111 4 164 -1.28% | 4 903 5 407 -9.33% | 6 083 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 876 1 155 -24.12% | 1 304 1 295 0.71% | 1 870 1 949 -4.03% | 3 940 3 977 -0.93% | 5 103 5 139 -0.71% | 6 063 |
|
Net income Million TWD | Released Forecast Spread | 663 877 -24.42% | 1 030 1 019 1.09% | 1 403 1 456 -3.61% | 3 021 3 099 -2.52% | 4 106 4 090 0.37% | 4 844 |
|
EPS TWD | Released Forecast Spread | 2,74 3,61 -24.1% | 4,22 4,20 0.6% | 5,47 5,56 -1.62% | 11,6 12,0 -3.14% | 15,7 15,6 1.05% | 18,5 |
| Announcement Date | 19/03/20 | 26/03/21 | 16/03/22 | 14/03/23 | 15/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 2 803 2 927 -4.24% | 3 161 2 998 5.46% | 2 910 2 954 -1.47% | 5 389 5 224 3.15% | 3 172 2 971 6.76% | 4 524 4 058 11.49% | 4 442 4 205 5.62% | 4 573 4 498 1.67% | 3 419 3 464 -1.28% | 4 237 | 5 100 | 5 253 | 4 235 | 4 864 |
|
EBITDA Million TWD | Released Forecast Spread | 587 680 -13.72% | 833 814 2.27% | 730 782 -6.6% | 2 881 1 076 167.76% | 1 964 936 109.88% | 1 908 1 711 11.52% | 1 775 1 739 2.05% | 469 875 -46.34% | 1 352 | 1 979 | 2 126 | 982 | ||
|
EBIT Million TWD | Released Forecast Spread | 393 472 -16.84% | 624 591 5.5% | 490 494 -0.7% | 2 641 2 176 21.38% | 356 411 -13.25% | 1 664 1 327 25.36% | 1 614 1 445 11.65% | 1 482 1 612 -8.05% | 143 696 -79.4% | 1 455 | 1 852 | 1 933 | 1 095 | 1 766 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 320 391 -18.05% | 589 504 16.74% | 427 424 0.58% | 2 630 2 088 25.96% | 295 333 -11.47% | 1 505 1 056 42.48% | 1 524 1 378 10.55% | 1 566 1 574 -0.51% | 508 556 -8.64% | 1 390 | 1 840 | 1 948 | 1 123 | 1 729 |
|
Net income Million TWD | Released Forecast Spread | 251 296 -14.97% | 446 381 17.03% | 328 318 3.04% | 2 079 1 554 33.83% | 168 247 -32.01% | 1 194 803 48.73% | 1 266 1 054 20.05% | 1 246 1 225 1.73% | 400 415 -3.57% | 1 086 | 1 451 | 1 530 | 877 | 1 351 |
|
EPS TWD | Released Forecast Spread | 0,95 1,13 -15.74% | 1,71 1,45 17.77% | 1,25 1,22 2.74% | 7,93 5,94 33.45% | 0,63 0,94 -32.98% | 4,55 3,07 48.45% | 4,84 4,03 20.22% | 4,76 4,69 1.6% | 1,53 1,46 4.51% | 4,14 | 5,55 | 5,85 | 3,35 | 5,10 |
| Announcement Date | 16/03/22 | 13/05/22 | 11/08/22 | 10/11/22 | 14/03/23 | 15/05/23 | 11/08/23 | 10/11/23 | 15/03/24 | - | - | - | - | - |
| Today 06:30 am | PERRIGO COMPANY PLC: Q1 2024 Earnings Release |
| Today 04:00 pm | OCULAR THERAPEUTIX, INC.: Q1 2024 Earnings Release |
| Today 04:01 pm | LIGAND PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
| Today 04:05 pm | SIGA TECHNOLOGIES, INC.: Q1 2024 Earnings Release |
| 2024-05-07 | IMMUNOCORE HOLDINGS PLC: Q1 2024 Earnings Release (Projected) |
| 2024-05-07 | AMPHASTAR PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-07 | TARSUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-07 | AVADEL PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 2024-05-07 | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q1 2024 Earnings Release (Projected) |
| 2024-05-07 | CAMURUS AB: Q1 2024 Earnings Release |
Past sector events for Lotus Pharmaceutical Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1795 Stock
- 1795 Stock
- Calendar Lotus Pharmaceutical Co., Ltd.